This small cap profited big time from the drought in its June 2018 result

Duxton Water Ltd (ASX:D2O) had a strong half year.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last week, small cap Duxton Water Ltd (ASX: D2O) reported its half year result for the six months to 30 June 2018.

As a reminder, Duxton Water owns water entitlements and leases them out on either short-term or long-term contracts.

The company revealed that revenue grew by 348% to nearly $8 million on the back of higher prices for the water leases and additional water entitlements owned in its portfolio.

Net profit after tax (NPAT) grew by 20% to $1.17 million. The rise wasn't as strong as revenue growth due to an increase in cost of sales, performance fees paid to management thanks to Duxton Water's strong performance and an impairment of water allocation.

Earnings per share (EPS) grew by 6.67% to 0.016 cents and the dividend was increased by 8.7% to 2.5 cents per share from 2.3 cents a year ago.

Duxton Water's portfolio received a $15.8 million uplift in valuation thanks to water price rises.

In the six months since the end of its 2017 financial year, Duxton Water's fair market value balance sheet showed a 36% increase in total net assets to $114.3 million. The fair value is important because businesses show the water entitlements at cost on their balance sheet, not the current price – the fair market value – they could get for them.

The net asset value (NAV) per share increased by 8.2% to $1.277 in the six months to 30 June 2018.

The January to June period was one of the driest on record, with irrigators drawing down on the carry over and allocation reserves that had been built during the wet spring of 2016. Many irrigators overused their allocation, therefore they had to buy entitlements to avoid fines.

Duxton Water is confident that with its current water entitlement portfolio and weighting towards high security entitlements, it is well positioned to support its tenants and other irrigators through the remainder of this water year and beyond.

Foolish takeaway

Duxton Water seems fairly valued now that its share price has caught up (and overtaken) the last monthly update of NAV. However, it may still be able to create pleasing growth over the coming years as water entitlements become more valuable with growing demand for food and drier conditions.

Motley Fool contributor Tristan Harrison owns shares of DUXTON FPO. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »